- Home
- CALC vs RGS Comparison
CALC vs RGS Comparison
Compare CALC & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- RGS
- Stock Information
- Founded
- CALC 2011
- RGS 1922
- Country
- CALC United States
- RGS United States
- Employees
- CALC N/A
- RGS N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- RGS Other Consumer Services
- Sector
- CALC Health Care
- RGS Consumer Discretionary
- Exchange
- CALC Nasdaq
- RGS Nasdaq
- Market Cap
- CALC 48.1M
- RGS 47.4M
- IPO Year
- CALC N/A
- RGS 1991
- Fundamental
- Price
- CALC $3.09
- RGS $25.55
- Analyst Decision
- CALC Strong Buy
- RGS
- Analyst Count
- CALC 2
- RGS 0
- Target Price
- CALC $14.50
- RGS N/A
- AVG Volume (30 Days)
- CALC 53.0K
- RGS 16.5K
- Earning Date
- CALC 08-12-2025
- RGS 11-05-2025
- Dividend Yield
- CALC N/A
- RGS N/A
- EPS Growth
- CALC N/A
- RGS 20.23
- EPS
- CALC N/A
- RGS 46.10
- Revenue
- CALC N/A
- RGS $210,134,000.00
- Revenue This Year
- CALC N/A
- RGS N/A
- Revenue Next Year
- CALC N/A
- RGS N/A
- P/E Ratio
- CALC N/A
- RGS $0.55
- Revenue Growth
- CALC N/A
- RGS 3.52
- 52 Week Low
- CALC $1.42
- RGS $15.00
- 52 Week High
- CALC $5.97
- RGS $29.28
- Technical
- Relative Strength Index (RSI)
- CALC 56.35
- RGS 68.96
- Support Level
- CALC $3.04
- RGS $22.00
- Resistance Level
- CALC $3.38
- RGS $25.58
- Average True Range (ATR)
- CALC 0.24
- RGS 1.37
- MACD
- CALC 0.02
- RGS 0.56
- Stochastic Oscillator
- CALC 58.57
- RGS 97.64
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About RGS Regis Corporation
Regis Corp owns, franchises, and operates beauty salons throughout North America and the United Kingdom. The company's locations provide salon products and services to the mass market, including haircutting, styling, and hair coloring. The vast majority of Regis' salons are in strip malls, shopping centers, and Wal-Mart stores in North America and serve price-conscious customers. The company derives the majority of its revenue from these locations. The sale of products also contributes a relatively significant percentage of total sales. Regis also operates a smaller portfolio of premium salons across North America and the U.K. The company's majority brands include SmartStyle, Cost Cutters, and Supercuts.